Literature DB >> 26659843

Mitral regurgitation. Timing of surgery or interventional treatment.

A Vahanian1, B Iung2.   

Abstract

The treatment of mitral regurgitation has changed in recent years because of improvements in the surgical treatment, in particular valve repair, and the advent of interventional techniques, mainly percutaneous edge-to-edge repair. Regardless of the technique used, better results are obtained for interventions in primary mitral regurgitation than in secondary mitral regurgitation, which remains a challenge. Further developments are expected in the future thanks to a better understanding of the epidemiology and the mechanisms of secondary mitral regurgitation, the development of interventional techniques, and a careful evaluation.

Entities:  

Keywords:  Cardiac surgery; Edge-to-edge repair; Mitral regurgitation; Percutaneous intervention; Review

Mesh:

Year:  2016        PMID: 26659843     DOI: 10.1007/s00059-015-4382-4

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  42 in total

1.  Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 1: Clinical Trial Design Principles: A Consensus Document From the Mitral Valve Academic Research Consortium.

Authors:  Gregg W Stone; Alec S Vahanian; David H Adams; William T Abraham; Jeffrey S Borer; Jeroen J Bax; Joachim Schofer; Donald E Cutlip; Mitchell W Krucoff; Eugene H Blackstone; Philippe Généreux; Michael J Mack; Robert J Siegel; Paul A Grayburn; Maurice Enriquez-Sarano; Patrizio Lancellotti; Gerasimos Filippatos; Arie Pieter Kappetein
Journal:  J Am Coll Cardiol       Date:  2015-07-21       Impact factor: 24.094

2.  MitraClip therapy in surgical high-risk patients: identification of echocardiographic variables affecting acute procedural outcome.

Authors:  Edith Lubos; Michael Schlüter; Eik Vettorazzi; Britta Goldmann; Daniel Lubs; Johannes Schirmer; Hendrik Treede; Hermann Reichenspurner; Stefan Blankenberg; Stephan Baldus; Volker Rudolph
Journal:  JACC Cardiovasc Interv       Date:  2014-03-14       Impact factor: 11.195

3.  Clinical outcome of critically ill, not fully recompensated, patients undergoing MitraClip therapy.

Authors:  Volker Rudolph; Michael Huntgeburth; Ralph Stephan von Bardeleben; Peter Boekstegers; Edith Lubos; Wolfgang Schillinger; Taoufik Ouarrak; Holger Eggebrecht; Christian Butter; Björn Plicht; Andreas May; Olaf Franzen; Joachim Schofer; Jochen Senges; Stephan Baldus
Journal:  Eur J Heart Fail       Date:  2014-10-15       Impact factor: 15.534

4.  Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 2: Endpoint Definitions: A Consensus Document From the Mitral Valve Academic Research Consortium.

Authors:  Gregg W Stone; David H Adams; William T Abraham; Arie Pieter Kappetein; Philippe Généreux; Pascal Vranckx; Roxana Mehran; Karl-Heinz Kuck; Martin B Leon; Nicolo Piazza; Stuart J Head; Gerasimos Filippatos; Alec S Vahanian
Journal:  J Am Coll Cardiol       Date:  2015-07-21       Impact factor: 24.094

5.  Off-pump transapical implantation of artificial neo-chordae to correct mitral regurgitation: the TACT Trial (Transapical Artificial Chordae Tendinae) proof of concept.

Authors:  Joerg Seeburger; Mauro Rinaldi; Sten Lyager Nielsen; Stefano Salizzoni; Ruediger Lange; Markus Schoenburg; Ottavio Alfieri; Michael Andrew Borger; Friedrich Wilhelm Mohr; Audrius Aidietis
Journal:  J Am Coll Cardiol       Date:  2013-09-24       Impact factor: 24.094

6.  Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction.

Authors:  Audrey H Wu; Keith D Aaronson; Steven F Bolling; Francis D Pagani; Kathy Welch; Todd M Koelling
Journal:  J Am Coll Cardiol       Date:  2005-02-01       Impact factor: 24.094

7.  The MITRA-FR study: design and rationale of a randomised study of percutaneous mitral valve repair compared with optimal medical management alone for severe secondary mitral regurgitation.

Authors:  Jean-François Obadia; Xavier Armoiry; Bernard Iung; Thierry Lefèvre; Nathan Mewton; David Messika-Zeitoun; Bertrand Cormier; Julien Berthiller; Delphine Maucort-Boulch; Florent Boutitie; Bernadette Vaz; Jean-Noël Trochu; Alec Vahanian
Journal:  EuroIntervention       Date:  2015-03       Impact factor: 6.534

Review 8.  Early surgical intervention or watchful waiting for the management of asymptomatic mitral regurgitation: a systematic review and meta-analysis.

Authors:  Andrew B Goldstone; William L Patrick; Jeffrey E Cohen; Chiaka N Aribeana; Rita Popat; Y Joseph Woo
Journal:  Ann Cardiothorac Surg       Date:  2015-05

9.  Acute outcomes after MitraClip therapy in highly aged patients: results from the German TRAnscatheter Mitral valve Interventions (TRAMI) Registry.

Authors:  Wolfgang Schillinger; Mark Hünlich; Stephan Baldus; Taoufik Ouarrak; Peter Boekstegers; Ulrich Hink; Christian Butter; Raffi Bekeredjian; Björn Plicht; Horst Sievert; Joachim Schofer; Jochen Senges; Thomas Meinertz; Gerd Hasenfuß
Journal:  EuroIntervention       Date:  2013-05-20       Impact factor: 6.534

10.  Mitral-valve repair versus replacement for severe ischemic mitral regurgitation.

Authors:  Michael A Acker; Michael K Parides; Louis P Perrault; Alan J Moskowitz; Annetine C Gelijns; Pierre Voisine; Peter K Smith; Judy W Hung; Eugene H Blackstone; John D Puskas; Michael Argenziano; James S Gammie; Michael Mack; Deborah D Ascheim; Emilia Bagiella; Ellen G Moquete; T Bruce Ferguson; Keith A Horvath; Nancy L Geller; Marissa A Miller; Y Joseph Woo; David A D'Alessandro; Gorav Ailawadi; Francois Dagenais; Timothy J Gardner; Patrick T O'Gara; Robert E Michler; Irving L Kron
Journal:  N Engl J Med       Date:  2013-11-18       Impact factor: 91.245

View more
  1 in total

1.  [Cardioband®: Where do we stand, who are suitable patients?]

Authors:  C Frerker; T Schmidt; R Pfister; M I Körber; V Mauri; M Wösten; S Baldus
Journal:  Herz       Date:  2019-11       Impact factor: 1.443

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.